Bronchiolitis obliterans following hematopoietic stem cell transplantation: A clinical update

Clinical Transplantation

Volumn 24, Issue 3, 2010, Pages 291-306

  Pandya, Chirag M ^a   Soubani, Ayman O ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchiolitis obliterans; Complications; Hematopoietic stem cells; Pulmonary disease; Transplantation

Indexed keywords

ALEFACEPT; AZATHIOPRINE; AZITHROMYCIN; BUDESONIDE PLUS FORMOTEROL; BUSULFAN; CYCLOSPORIN A; DACLIZUMAB; FLUTICASONE PROPIONATE; IMATINIB; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB; TACROLIMUS; THALIDOMIDE; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS; BRONCHITIS; BRONCHOSCOPY; CHRONIC MYELOID LEUKEMIA; COUGHING; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DRUG MEGADOSE; DYSPNEA; FORCED EXPIRATORY VOLUME; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEREDITY; HUMAN; IMMUNOGLOBULIN DEFICIENCY; INCIDENCE; INNATE IMMUNITY; LUNG FUNCTION; LUNG INJURY; PATHOGENESIS; PNEUMOMEDIASTINUM; PNEUMOPERICARDIUM; PNEUMOTHORAX; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEX DIFFERENCE; SINUSITIS; SPIROMETRY; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; WHEEZING; PATHOLOGY;

BRONCHIOLITIS OBLITERANS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; RISK FACTORS;

EID: 77954163520     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01122.x     Document Type: Review

References (121)

1. Krowka MJ, Rosenow EC, Hoagland HC. Pulmonary complications of bone marrow transplantation. Chest 1985, 87:237.
2. Crawford SW, Hackman RC. Clinical course of idiopathic pneumonia after bone marrow transplantation. Am Rev Respir Dis 1993, 147:1393.
3. Quabeck K. The lung as a critical organ in marrow transplantation. Bone Marrow Transplant 1994, 14(Suppl. 4):S19.
4. Yen KT, Lee AS, Krowka MJ, Burger CD. Pulmonary complications in bone marrow transplantation: a practical approach to diagnosis and treatment. Clin Chest Med 2004, 25:189.
5. Kotloff RM, Ahya VN, Crawford SW. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2004, 170:22.
6. Sirithanakul K, Salloum A, Klein JL, Soubani AO. Pulmonary complications following hematopoietic stem cell transplantation: diagnostic approaches. Am J Hematol 2005, 80:137.
7. Beschorner WE, Saral R, Hutchins GM, Tutschka PJ, Santos GW. Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone-marrow transplants. N Engl J Med 1978, 299:1030.
8. Roca J, Granena A, Rodriguez-Roisin R, Alvarez P, Agusti-Vidal A, Rozman C. Fatal airway disease in an adult with chronic graft-versus-host disease. Thorax 1982, 37:77.
9. Wyatt SE, Nunn P, Hows JM. Airways obstruction associated with graft versus host disease after bone marrow transplantation. Thorax 1984, 39:887. (Abstract)
10. Urbanski SJ, Kossakowska AE, Curtis J. Idiopathic small airways pathology in patients with graft-versus-host disease following allogeneic bone marrow transplantation. Am J Surg Pathol 1987, 11:965.
11. Clark JG, Schwartz DA, Flournoy N, Sullivan KM, Crawford SW, Thomas ED. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 1987, 107:648.
12. Chan CK, Hyland RH, Hutcheon MA. Small airways disease in recipients of allogeneic bone marrow transplants. An analysis of 11 cases and a review of the literature. Medicine (Baltimore) 1987, 66:327.
13. Holland HK, Wingard JR, Beschorner WE, Saral R, Santos GW. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v host disease and low serum IgG. Blood 1988, 72:621.
14. Clark JG, Crawford SW, Madtes DK, Sullivan KM. Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 1989, 111:368.
15. Schwarer AP, Hughes JM, Trotman-Dickenson B, Krausz T, Goldman JM. A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation. Transplantation 1992, 54:1002.
16. Payne L, Chan CK, Fyles G. Cyclosporine as possible prophylaxis for obstructive airways disease after allogeneic bone marrow transplantation. Chest 1993, 104:114.
17. Schultz KR, Green GJ, Wensley D. Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood 1994, 84:3212.
18. Curtis DJ, Smale A, Thien F, Schwarer AP, Szer J. Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 1995, 16:169.
19. Philit F, Wiesendanger T, Archimbaud E, Mornex JF, Brune J, Cordier JF. Post-transplant obstructive lung disease (" bronchiolitis obliterans" ): a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J 1995, 8:551.
20. Yokoi T, Hirabayashi N, Ito M. Broncho-bronchiolitis obliterans as a complication of bone marrow transplantation: a clinicopathological study of eight autopsy cases. Nagoya BMT Group. Virchows Arch 1997, 431:275.
21. Sanchez J, Torres A, Serrano J. Long-term follow-up of immunosuppressive treatment for obstructive airways disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997, 20:403.
22. Palmas A, Tefferi A, Myers JL. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol 1998, 100:680.
23. Ringden O, Remberger M, Ruutu T. Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group. Blood 1999, 93:2196.
24. Dudek AZ, Mahaseth H, DeFor TE, Weisdorf DJ. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 2003, 9:657.
25. Chien JW, Martin PJ, Gooley TA. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003, 168:208.
26. Sakaida E, Nakaseko C, Harima A. Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft versus-leukemia effect. Blood 2003, 102:4236.
27. Marras TK, Chan CK, Lipton JH, Messner HA, Szalai JP, Laupacis A. Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation. Bone Marrow Transplant 2004, 33:509.
28. Chien JW, Martin PJ, Flowers ME, Nichols WG, Clark JG. Implications of early airflow decline after myeloablative allogeneic stem cell transplantation. Bone Marrow Transplant 2004, 33:759.
29. Ratjen F, Rjabko O, Kremens B. High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children. Bone Marrow Transplant 2005, 36:135.
30. Khalid M, Al Saghir A, Saleemi S. Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study. Eur Respir J 2005, 25:490.
31. Yoshihara S, Tateishi U, Ando T. Lower incidence of bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning. Bone Marrow Transplant 2005, 35:1195.
32. Santo Tomas LH, Loberiza FR, Klein JP. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest 2005, 128:153.
33. Duncan CN, Buonanno MR, Barry EV. Bronchiolitis obliterans following pediatric allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2008, 41:971.
34. Afessa B, Litzow MR, Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001, 28:425.
35. Paz HL, Crilley P, Patchefsky A, Schiffman RL, Brodsky I. Bronchiolitis obliterans after autologous bone marrow transplantation. Chest 1992, 101:775.
36. Frankovich J, Donaldson SS, Lee Y, Wong RM, Amylon M, Verneris MR. High-dose therapy and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin's disease: atopy predicts idiopathic diffuse lung injury syndromes. Biol Blood Marrow Transplant 2001, 7:49.
37. Ohnuma K, Toyoda Y, Ishida Y. Fatal obstructive lung disease after haploidentical sibling cord blood transplantation. Bone Marrow Transplant 1998, 21:939.
38. Endo M, Furukawa H, Aramaki T. Unusual late pulmonary complication in a child after umbilical cord blood transplantation: high-resolution CT-pathologic correlation. J Thorac Imaging 2005, 20:103.
39. Prince DS, Wingard JR, Saral R, Santos GW, Wise RA. Longitudinal changes in pulmonary function following bone marrow transplantation. Chest 1989, 96:301.
40. Chien JW, Maris MB, Sandmaier BM, Maloney DG, Storb RF, Clark JG. Comparison of lung function after myeloablative and 2 Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005, 11:288.
41. Marras TK, Chan CK. Obliterative bronchiolitis complicating bone marrow transplantation. Semin Respir Crit Care Med 2003, 24:531.
42. Nakane T, Nakamae H, Kamoi H. Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2008, 42:43.
43. Hildebrandt GC, Granell M, Urbano-Ispizua A. Recipient NOD2/CARD15 variants: a novel independent risk factor for the development of bronchiolitis obliterans after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2008, 14:67.
44. Epler GR. Bronchiolitis obliterans and airways obstruction associated with graft-versus-host disease. Clin Chest Med 1988, 9:551.
45. Au WY, Ho JC, Lie AK. Respiratory ciliary function in bone marrow recipients. Bone Marrow Transplant 2001, 27:1147.
46. Vilchez RA, Dauber J, Kusne S. Infectious etiology of bronchiolitis obliterans: the respiratory viruses connection myth or reality? Am J Transplant 2003, 3:245.
47. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001, 344:1917.
48. Benden C, Aurora P, Curry J, Whitmore P, Priestley L, Elliott MJ. High prevalence of gastroesophageal reflux in children after lung transplantation. Pediatr Pulmonol 2005, 40:68.
49. Hadjiliadis D, Duane Davis R, Steele MP. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant 2003, 17:363.
50. Davis RD, Lau CL, Eubanks S. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003, 125:533.
51. Ing AJ. Interstitial lung disease and gastroesophageal reflux. Am J Med 2001, 8A:41S.
52. Trisolini R, Bandini G, Stanzani M. Morphologic changes leading to bronchiolitis obliterans in a patient with delayed non-infectious lung disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001, 28:1167.
53. Yousem SA. The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients. Hum Pathol 1995, 26:668.
54. Ditschkowski M, Elmaagacli AH, Trenschel R. T-cell depletion prevents from bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia after allogeneic hematopoietic stem cell transplantation with related donors. Haematologica 2007, 92:558.
55. Panoskaltsis-Mortari A, Tram KV, Price AP, Wendt CH, Blazar BR. A new murine model for bronchiolitis obliterans post-bone marrow transplant. Am J Respir Crit Care Med 2007, 176:713.
56. Holler E, Kolb HJ, Moller A. Increased serum levels of tumor necrosis factor a precede major complications of bone marrow transplantation. Blood 1990, 75:1011.
57. Rowbottom AW, Riches PG, Downie C, Hobbs JR. Monitoring cytokine production in peripheral blood during acute graft-versus-host disease following allogeneic bone marrow transplantation. Bone Marrow Transplant 1993, 12:635.
58. Hauber HP, Mikkilä A, Erich JM. TNF-alpha, interleukin-10 and interleukin-18 expression in cells of the bronchoalveolar lavage in patients with pulmonary complications following bone marrow or peripheral stem cell transplantation: a preliminary study. Bone Marrow Transplant 2002, 30:485.
59. Garantziotis S, Palmer SM, Snyder LD. Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide. Transplantation 2007, 84:1012.
60. Kallio EA, Koskinen PK, Aavik E, Vaali K, Lemstom KB. Role of nitric oxide in experimental obliterative bronchiolitis (chronic rejection) in the rat. J Clin Invest 1997, 100:2984.
61. Kanamori H, Fujisawa S, Tsuburai T. Increased exhaled nitric oxide in bronchiolitis obliterans organizing pneumonia after allogeneic bone marrow transplantation. Transplantation 2002, 74:1356.
62. Galanis E, Litzow MR, Tefferi A, Scott JP. Spontaneous pneumomediastinum in a patient with bronchiolitis obliterans after bone marrow transplantation. Bone Marrow Transplant 1997, 20:695.
63. Cazzadori A, Di Perri G, Bonora S, Lanzafame M, Allegranzi B, Concia E. Fatal pneumothorax complicating BAL in a bone marrow transplant recipient with bronchiolitis obliterans. Chest 1997, 111:1468.
64. Kumar S, Tefferi A. Spontaneous pneumomediastinum and subcutaneous emphysema complicating bronchiolitis obliterans after allogeneic bone marrow transplantation - case report and review of literature. Ann Hematol 2001, 80:430.
65. Garg K, Lynch DA, Newell JD, King TE. Proliferative and constrictive bronchiolitis: classification and radiologic features. AJR Am J Roentgenol 1994, 162:803.
66. Jung JI, Jung WS, Hahn ST, Min CK, Kim CC, Park SH. Bronchiolitis obliterans after allogeneic bone marrow transplantation: HRCT findings. Korean J Radiol 2004, 5:107.
67. Padley SP, Adler BD, Hansell DM, Muller NL. Bronchiolitis obliterans: high resolution CT findings and correlation with pulmonary function tests. Clin Radiol 1993, 47:236.
68. Lee ES, Gotway MB, Reddy GP, Golden JA, Keith FM, Webb WR. Early bronchiolitis obliterans following lung transplantation: accuracy of expiratory thin-section CT for diagnosis. Radiology 2000, 216:472.
69. Bankier AA, Van Muylem A, Knoop C, Estenne M, Gevenois PA. Bronchiolitis obliterans syndrome in heart lung transplant recipients: diagnosis with expiratory CT. Radiology 2001, 218:533.
70. Boehlert A, Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J 2003, 22:1007.
71. Estenne M, Maurer JR, Boehler A. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002, 21:297.
72. Soubani AO, Uberti JP. Bronchiolitis obliterans following haematopoietic stem cell transplantation. Eur Respir J 2007, 29:1007.
73. Guihot A, Becquemin MH, Couderc LJ. Telemetric monitoring of pulmonary function after allogeneic hematopoietic stem cell transplantation. Transplantation 2007, 15:554.
74. Soubani AO, Miller KB, Hassoun PM. Pulmonary complications of bone marrow transplantation. Chest 1996, 109:1066.
75. St John RC, Gadek JE, Tutschka PJ, Kapoor N, Dorinsky PM. Analysis of airflow obstruction by bronchoalveolar lavage following bone marrow transplantation. Implications for pathogenesis and treatment. Chest 1990, 98:600.
76. Chan C, Spaner D, Hyland R. Bronchiolitis obliterans after bone marrow transplantation. Blood 1989, 73:355.
77. Ringdén O. Introduction to graft-versus-host disease. Biol Blood Marrow Transplant 2005, 11:S17.
78. Filipovich AH, Weisdorf D, Pavletic S. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 12:945.
79. Crawford SW, Clark JG. Bronchiolitis associated with bone marrow transplantation. Clin Chest Med 1993, 14:741.
80. Crawford SW. Supportive care in bone marrow transplantation: pulmonary complications. Cancer Treat Res 1997, 77:231.
81. Ratanatharathorn V, Ayash L, Lazarus HM, Fu J, Uberti JP. Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplant 2001, 28:121.
82. Patriarca F, Skert C, Sperotto A. Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation. Bone Marrow Transplant 2004, 33:751.
83. Heaton DC. Failure of thalidomide to control bronchiolitis obliterans post bone marrow transplant. Bone Marrow Transplant 1989, 4:598.
84. Parker PM, Chao N, Nademanee A. Thalidomide as salvage therapy for chronic graft-versus-host disease. Blood 1995, 86:3604.
85. Forsyth CJ, Cremer PD, Torzillo P, Iland HJ, Young GA. Thalidomide responsive chronic pulmonary GVHD. Bone Marrow Transplant 1996, 17:291.
86. Rovelli A, Arrigo C, Nesi F. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children. Bone Marrow Transplant 1998, 21:577.
87. Browne PV, Weisdorf DJ, DeFor T. Response to thalidomide therapy in refractory chronic graft-versus host disease. Bone Marrow Transplant 2000, 26:865.
88. Sano H, Kikuta A, Ito M, Nemoto K, Hojo H, Ohto H. Successful treatment with combined anti-thymocyte globulin and methylprednisolone for bronchiolitis obliterans after allogeneic bone marrow transplantation in a child with chronic myelogenous leukaemia. Rinsho Ketsueki 2002, 43:23. (Abstract)
89. Sullivan KM, Storek J, Kopecky KJ. A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery. Biol Blood Marrow Transplant 1996, 2:44.
90. Couriel DR, Hicks K, Giralt S, Champlin RE. Role of tumor necrosis factor-a inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation. Curr Opin Oncol 2000, 12:582.
91. Ishii T, Manabe A, Ebihara Y. Improvement in bronchiolitis obliterans organizing pneumonia in a child after allogeneic bone marrow transplantation by a combination of oral prednisolone and low dose erythromycin. Bone Marrow Transplant 2000, 26:907.
92. Gerhardt SG, McDyer JF, Girgis RE, Conte JV, Yang SC, Orens JB. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Am J Respir Crit Care Med 2003, 168:121.
93. Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2006, 174:566.
94. Gottlieb J, Szangolies J, Koehnlein T, Golpon H, Simon A, Welte T. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2008, 85:36.
95. Siddiqui J. Immunomodulatory effects of macrolides: implications for practicing clinicians. Am J Med 2004, 9A:26S.
96. Speich R, Boehler A, Russi EW, Weder W. A case report of a double-blind, randomized trial of inhaled steroids in a patient with lung transplant bronchiolitis obliterans. Respiration 1997, 64:375.
97. Whitford H, Orsida B, Kotsimbos T. Bronchoalveolar lavage cellular profiles in lung transplantation: the effect of inhaled corticosteroids. Ann Transplant 2000, 5:31.
98. De Soyza A, Fisher AJ, Small T, Corris PA. Inhaled corticosteroids and the treatment of lymphocytic bronchiolitis following lung transplantation. Am J Respir Crit Care Med 2001, 164:1209.
99. Whitford H, Walters EH, Levvey B. Addition of inhaled corticosteroids to systemic immunosuppression after lung transplantation: a double-blind, placebo-controlled trial. Transplantation 2002, 73:1793.
100. Zheng L, Walters EH, Wang N. Effect of inhaled fluticasone propionate on BAL TGF-b1 and bFGF concentrations in clinically stable lung transplant recipients. J Heart Lung Transplant 2004, 23:446.
101. Bashoura L, Gupta S, Jain A. Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation. Bone Marrow Transplant 2008, 41:63.
102. Bergeron A, Feuillet S, Meignin V. Late onset, non-infectious pulmonary complications after haematological stem cell transplantation. Rev Mal Respir 2008, 25:173.
103. Foss FM. Extracorporeal photophoresis in the treatment of graft-vs-host disease. J Cutan Med Surg 2003, 7(Suppl. 4):13.
104. Rossetti F, Zulian F, Dall'Amico R, Messina C, Montini G, Zacchello F. Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus host disease. Transplantation 1995, 59:149.
105. Foss FM, DiVenuti GM, Chin K. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant 2005, 35:1187.
106. Dall'Amico R, Rossetti F, Zulian F. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. Br J Haematol 1997, 97:848.
107. Chiild FJ, Ratnavel R, Watkins P. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 1999, 23:881.
108. Greinix HT, Volc-Platzer B, Rabitsch W. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood 1998, 92:3098.
109. Oyan B, Koc Y, Emri S, Kansu E. Improvement of chronic pulmonary graft-vs-host disease manifesting as bronchiolitis obliterans organizing pneumonia following extracorporeal photopheresis. Med Oncol 2006, 23:125.
110. Alcindor T, Gorgun G, Miller KB. Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease. Blood 2001, 98:1622.
111. Majhail NS, Schiffer CA, Weisdorf DJ. Improvement of pulmonary function with imatinib mesylate in bronchiolitis obliterans following allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2006, 12:789.
112. Shapira MY, Abdul-Hai A, Resnick IB. Alefacept treatment for refractory chronic extensive GVHD. Bone Marrow Transplant 2009, 43:339.
113. Miano M, Cuzzubbo D, Terranova P. Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience. Bone Marrow Transplant 2009, 43:423.
114. Calhoon JH, Levine S, Anzueto A, Bryan CL, Trinkle JK. Lung transplantation in a patient with a prior bone marrow transplant. Chest 1992, 102:948.
115. Gascoigne A, Corris P. Lung transplants in patients with prior bone marrow transplants. Chest 1994, 105:327.
116. Svendsen UG, Aggestrup S, Heilmann C. Transplantation of a lobe of lung from mother to child following previous transplantation with maternal bone marrow. Eur Respir J 1995, 8:334.
117. Heath JA, Kurland G, Spray TL. Lung transplantation after allogeneic marrow transplantation in pediatric patients: the Memorial Sloan-Kettering experience. Transplantation 2001, 72:1986.
118. Boas SR, Noyes BE, Kurland G, Armitage J, Orenstein D. Pediatric lung transplantation for graft-versus-host disease following bone marrow transplantation. Chest 1994, 105:1584.
119. Rabitsch W, Deviatko E, Keil F. Successful lung transplantation for bronchiolitis obliterans after allogeneic marrow transplantation. Transplantation 2001, 71:1341.
120. Sano Y, Date H, Nagahiro I, Aoe M, Shimizu N. Living-donor lobar lung transplantation for bronchiolitis obliterans after bone marrow transplantation. Ann Thorac Surg 2005, 79:1051.
121. Matsuzaki A, Suminoe A. Lung transplantation after hematopoietic stem cell transplantation from the same living donor in a child with juvenile myelomonocytic leukemia and bronchiolitis obliterans. Pediatr Blood Cancer 2008, 51:567.